MedPath
HSA Approval

LOVIR TABLETS 400 mg

SIN09629P

LOVIR TABLETS 400 mg

LOVIR TABLETS 400 mg

February 12, 1998

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

J05AB01

aciclovir

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN BHD

Active Ingredients

ACYCLOVIR

400 mg

Acyclovir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LOVIR TABLETS 400 mg - HSA Approval | MedPath